Wang Y, Xie H, Ma J, Du T, Gao S, Chen Y, Lin SY, Liang D
Wang Y, Xie H, Ma J, Du T, Gao S, Chen Y, Lin SY, Liang D. Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer. Pharmaceutics. 2025 Aug 13; 17(8).
Drug Metabolism and Pharmacokinetic Evaluation of a Novel RNase H2 Inhibitor for the Treatment of Triple-Negative Breast Cancer.
Wang Y, Ma J, Martinez ED, Liang D, Xie H
Journal of pharmaceutical and biomedical analysis
Wang Y, Ma J, Martinez ED, Liang D, Xie H. A UHPLC-MS/MS method for the quantification of JIB-04 in rat plasma: Development, validation and application to pharmacokinetics study. J Pharm Biomed Anal. 2020 Nov 30; 191:113587.
A UHPLC-MS/MS method for the quantification of JIB-04 in rat plasma: Development, validation and application to pharmacokinetics study.
Ekpenyong O, Cooper C, Ma J, Guy NC, Payan AN, Ban F, Cherkasov A, Cox MB, Liang D, Xie H
Ekpenyong O, Cooper C, Ma J, Guy NC, Payan AN, Ban F, Cherkasov A, Cox MB, Liang D, Xie H. Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer. Pharmaceuticals (Basel). 2020 Nov 13; 13(11).
Bioanalytical Assay Development and Validation for the Pharmacokinetic Study of GMC1, a Novel FKBP52 Co-chaperone Inhibitor for Castration Resistant Prostate Cancer.
Rincon Nigro M, Ma J, Awosemo OT, Xie H, Olaleye OA, Liang D
International journal of environmental research and public health
Rincon Nigro M, Ma J, Awosemo OT, Xie H, Olaleye OA, Liang D. Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study. Int J Environ Res Public Health. 2021 04 27; 18(9).
Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study.
Aviation, space, and environmental medicine
Wei B, Abobo CV, Ma J, Liang D. Gender differences in pharmacokinetics of antipyrine in a simulated weightlessness rat model. Aviat Space Environ Med. 2012 Jan; 83(1):8-13.
Gender differences in pharmacokinetics of antipyrine in a simulated weightlessness rat model.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Abobo CV, Ma J, Liang D. Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation. Nicotine Tob Res. 2012 Jul; 14(7):801-8.
Effect of menthol on nicotine pharmacokinetics in rats after cigarette smoke inhalation.
Milton SG, Robinson K, Ma J, Wei B, Poon IO, Liang D
Xenobiotica; the fate of foreign compounds in biological systems
Milton SG, Robinson K, Ma J, Wei B, Poon IO, Liang D. Biotransformation and pharmacokinetics of inositol hexanicotinate in rats. Xenobiotica. 2013 Sep; 43(9):817-22.
Biotransformation and pharmacokinetics of inositol hexanicotinate in rats.
Liang S, Bian X, Ma J, Arogunjo M, Deorukhkar AA, Krishnan S, Xie H
Liang S, Bian X, Ma J, Arogunjo M, Deorukhkar AA, Krishnan S, Xie H. Development and validation of a sensitive LC/MS/MS method for the determination of ?-tocotrienol in rat plasma: application to pharmacokinetic studies. Biomed Chromatogr. 2013 Jan; 27(1):58-66.
Development and validation of a sensitive LC/MS/MS method for the determination of ?-tocotrienol in rat plasma: application to pharmacokinetic studies.
Liang S, Sanchez-Espiridion B, Xie H, Ma J, Wu X, Liang D
Liang S, Sanchez-Espiridion B, Xie H, Ma J, Wu X, Liang D. Determination of proline in human serum by a robust LC-MS/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratification. Biomed Chromatogr. 2015 Apr; 29(4):570-7.
Determination of proline in human serum by a robust LC-MS/MS method: application to identification of human metabolites as candidate biomarkers for esophageal cancer early detection and risk stratification.
Chen Y, Bian X, Aliru M, Deorukhkar AA, Ekpenyong O, Liang S, John J, Ma J, Gao X, Schwartz J, Singh P, Ye Y, Krishnan S, Xie H
Chen Y, Bian X, Aliru M, Deorukhkar AA, Ekpenyong O, Liang S, John J, Ma J, Gao X, Schwartz J, Singh P, Ye Y, Krishnan S, Xie H. Hypoxia-targeted gold nanorods for cancer photothermal therapy. Oncotarget. 2018 May 29; 9(41):26556-26571.
Hypoxia-targeted gold nanorods for cancer photothermal therapy.
Gao X, Tsai RYL, Ma J, Bhupal PK, Liu X, Liang D, Xie H
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Gao X, Tsai RYL, Ma J, Bhupal PK, Liu X, Liang D, Xie H. Determination and validation of mycophenolic acid by a UPLC-MS/MS method: Applications to pharmacokinetics and tongue tissue distribution studies in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jan 01; 1136:121930.
J Chromatogr B Analyt Technol Biomed Life Sci
Determination and validation of mycophenolic acid by a UPLC-MS/MS method: Applications to pharmacokinetics and tongue tissue distribution studies in rats.
Ekpenyong O, Cooper C, Ma J, Liang D, Olaleye O, Xie H
Ekpenyong O, Cooper C, Ma J, Liang D, Olaleye O, Xie H. A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Oct 15; 1097-1098:35-43.
A simple, sensitive and reliable LC-MS/MS method for the determination of 7-bromo-5-chloroquinolin-8-ol (CLBQ14), a potent and selective inhibitor of methionine aminopeptidases: Application to pharmacokinetic studies.
Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H
Ekpenyong O, Gao X, Ma J, Cooper C, Nguyen L, Olaleye OA, Liang D, Xie H. Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases. Drug Des Devel Ther. 2020; 14:1263-1277.
Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases.
Gao X, Wu L, Tsai RYL, Ma J, Liu X, Chow DS, Liang D, Xie H
Gao X, Wu L, Tsai RYL, Ma J, Liu X, Chow DS, Liang D, Xie H. Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid. Pharmaceutics. 2021 Apr 17; 13(4).
Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid.
Liang D, Ma J, Wei B. Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness. Sci Rep. 2021 01 28; 11(1):2605.
Oral absorption and drug interaction kinetics of moxifloxacin in an animal model of weightlessness.
Chen Y, Gao X, Gupta R, Ma J, Dere R, Liang D, Xie H
Chen Y, Gao X, Gupta R, Ma J, Dere R, Liang D, Xie H. Development and Validation of an LC-MS/MS Method for AC1LPSZG and Pharmacokinetics Application in Rats. J Chromatogr Sci. 2022 Jan 01; 60(1):26-34.
Development and Validation of an LC-MS/MS Method for AC1LPSZG and Pharmacokinetics Application in Rats.
Awosemo O, Neelakantan H, Watowich S, Ma J, Wu L, Chow DS, Liang D
Awosemo O, Neelakantan H, Watowich S, Ma J, Wu L, Chow DS, Liang D. Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies. J Pharm Biomed Anal. 2021 Sep 10; 204:114255.
Development & validation of LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: Application to pharmacokinetic and oral bioavailability studies.
Gao X, Tsai RYL, Ma J, Wang Y, Liu X, Liang D, Xie H
Gao X, Tsai RYL, Ma J, Wang Y, Liu X, Liang D, Xie H. Determination of Oxaliplatin by a UHPLC-MS/MS Method: Application to Pharmacokinetics and Tongue Tissue Distribution Studies in Rats. Pharmaceuticals (Basel). 2021 Dec 31; 15(1).
Determination of Oxaliplatin by a UHPLC-MS/MS Method: Application to Pharmacokinetics and Tongue Tissue Distribution Studies in Rats.
Wang Y, Xie H, Alugubelli YR, Ma Y, Xu S, Ma J, Liu WR, Liang D
Wang Y, Xie H, Alugubelli YR, Ma Y, Xu S, Ma J, Liu WR, Liang D. Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies. Pharmaceuticals (Basel). 2022 May 27; 15(6).
Accurate Mass Identification of an Interfering Water Adduct and Strategies in Development and Validation of an LC-MS/MS Method for Quantification of MPI8, a Potent SARS-CoV-2 Main Protease Inhibitor, in Rat Plasma in Pharmacokinetic Studies.
Liang D, Ma J, Wei B, Poon IO, Bell EC, Bates TR
Liang D, Ma J, Wei B, Poon IO, Bell EC, Bates TR. Determination of inositol hexanicotinate in rat plasma by high performance liquid chromatography with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Feb 15; 863(1):172-6.
Determination of inositol hexanicotinate in rat plasma by high performance liquid chromatography with UV detection.
Wang Y, Ma J, Lin SY, Xie H, Liang D. A stability indicating LC-MS/MS method for quantification of a NOX Inhibitor R14 in its bisulfite adduct form for pharmacokinetic studies. J Pharm Biomed Anal. 2023 May 10; 228:115326.
A stability indicating LC-MS/MS method for quantification of a NOX Inhibitor R14 in its bisulfite adduct form for pharmacokinetic studies.
Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, Wu X
Liang D, Lin J, Grossman HB, Ma J, Wei B, Dinney CP, Wu X. Plasma vitamins E and A and risk of bladder cancer: a case-control analysis. Cancer Causes Control. 2008 Nov; 19(9):981-92.
Plasma vitamins E and A and risk of bladder cancer: a case-control analysis.
White L, Wu S, Ma J, Fang B, Liang D. Simultaneous determination and validation of oncrasin-266 and its metabolites by HPLC-MS/MS: Application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 15; 1033-1034:106-111.
Simultaneous determination and validation of oncrasin-266 and its metabolites by HPLC-MS/MS: Application to a pharmacokinetic study.
White L, Ma J, Liang S, Sanchez-Espiridion B, Liang D
White L, Ma J, Liang S, Sanchez-Espiridion B, Liang D. LC-MS/MS determination of d-mannose in human serum as a potential cancer biomarker. J Pharm Biomed Anal. 2017 Apr 15; 137:54-59.
LC-MS/MS determination of d-mannose in human serum as a potential cancer biomarker.
Sarkar M, Ma J, Tapadar S, Caggia S, Oyelere AK, Khan SA, Xie H
Sarkar M, Ma J, Tapadar S, Caggia S, Oyelere AK, Khan SA, Xie H. Development and validation of a sensitive LC-MS/MS assay of GT-14, a novel Gai2 inhibitor, in rat plasma, and its application in pharmacokinetic study. J Pharm Biomed Anal. 2024 Aug 01; 245:116183.
Development and validation of a sensitive LC-MS/MS assay of GT-14, a novel Gai2 inhibitor, in rat plasma, and its application in pharmacokinetic study.